The US Food and Drug Administration (FDA) has approved Celltrion’s biosimilars referencing Amgen’s bone disease therapy ...

Researchers have used machine learning to predict which patients with advanced bladder cancer are most likely to respond to ...

Agomab Therapeutics NV (‘Agomab’) today announced positive interim results from 44 patients completing treatment in the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal ...

Mumbai: Sun Pharmaceutical Industries Limited and Checkpoint Therapeutics, Inc. have announced that they have entered into an ...

Circulating tumor DNA may be a prognostic biomarker for relapse and early recurrence detection in resected early-stage ...

Sun Pharma to acquire Waltham, Massachusetts-based Checkpoint Therapeutics: Our Bureau, Mumbai Monday, March 10, 2025, 13:30 Hrs [IST] Sun Pharmaceutical Industries Limited and Ch ...